• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Massachusetts General Hospital

Beta Bionics touts results of bionic pancreas system study

June 10, 2019 By Nancy Crotti

Beta Bionics - updated logo

Beta Bionics’ iLet bionic pancreas system significantly increased the percentage of time that adults with Type 1 diabetes spent with glucose levels between 70–180 mg/dl when compared to usual care therapy, according to a new study. The study’s results also suggest that the iLet, using either the Senseonics (NYSE:SENS) Eversense continuous glucose monitoring system (CGM) […]

Filed Under: Clinical Trials, Diabetes, Drug-Device Combinations Tagged With: Beta Bionics, DexCom Inc., Massachusetts General Hospital, Senseonics

Beta Bionics starts new trial for bionic pancreas

May 24, 2019 By Nancy Crotti

Beta Bionics - updated logo

Boston-based Beta Bionics said this week that the first patients have begun home use of dasiglucagon in a clinical trial of the company’s iLet bionic pancreas system for people with Type 1 diabetes. The iLet device features an autonomous, dual-chamber infusion pump that is powered by dosing algorithms. Using machine learning and data from a continuous […]

Filed Under: Clinical Trials, Diabetes, Drug-Device Combinations, Featured, Uncategorized Tagged With: Beta Bionics, Massachusetts General Hospital, Zealand Pharma

Researchers use microparticles for targeted delivery of brain cancer therapy

August 7, 2018 By Sarah Faulkner

MIT - Glioma therapy

A team of researchers from Brigham & Women’s Hospital, Mass. Institute of Technology and Mass. General Hospital demonstrated that localizing the delivery of NAMPT inhibitors can extend survival in a mouse model of glioma, according to a paper published this week in the Proceedings of the National Academy of Sciences. The scientists created a test to […]

Filed Under: Drug-Device Combinations, Featured, Nanoparticles, Oncology, Pharmaceuticals, Research & Development Tagged With: Brigham & Women's Hospital, Massachusetts General Hospital, Massachusetts Institute of Technology

Generic drug shows promise as diabetes vaccine in small, years-long study

June 21, 2018 By Sarah Faulkner

diabetes

A cheap, generic tuberculosis vaccine lowered blood glucose levels in nine patients with Type I diabetes and the effects lasted for years, according to a study published this week in npj Vaccines. The study was conducted at Massachusetts General Hospital by Dr. Denise Faustman – a name that has long been saddled with controversy in the […]

Filed Under: Diabetes, Featured, Pharmaceuticals, Research & Development Tagged With: Massachusetts General Hospital

Study suggests Type II diabetes is being misdiagnosed in African-Americans

September 12, 2017 By Sarah Faulkner

diabetes

A test used to diagnose Type II diabetes and monitor blood sugar levels could be leaving hundreds of thousands of diabetic African Americans in the U.S. undiagnosed, according to a study published today in PLOS Medicine. The test uses 60 genetic variants, according to a team of scientists, and one of those genetic variants is found […]

Filed Under: Diabetes, Diagnostics, Featured, Research & Development Tagged With: Massachusetts General Hospital, wellcometrustsangerinstitute

Prolonging the lives & independence of Alzheimer’s patients with artificial intelligence

July 28, 2017 By Sarah Faulkner

MyndYou

With modern medicine and public health measures extending the average person’s life expectancy, a growing population is coming face to face with the challenges of age – including cognitive decline. Addressing the needs of people dealing with cognitive change is no simple task. And today’s healthcare workers are hungry for objective, meaningful data to help […]

Filed Under: Big Data, Diagnostics, Featured, Neurological Tagged With: Massachusetts General Hospital, myndyou

Antibiotic-eluting polymer could help treat prosthetic joint infections

July 19, 2017 By Sarah Faulkner

Antibiotic-eluting polymer

Researchers from Massachusetts General Hospital have developed an antibiotic-eluting polymer that could be used to treat infections in orthopedic implants, according to a report published in Nature Biomedical Engineering. Traditionally, treating a prosthetic joint infection involves removing an implant and replacing it with a temporary spacer made from antibiotic-releasing bone cement for at least six […]

Filed Under: Drug-Device Combinations, Featured, Implants, Orthopedics, Pharmaceuticals, Research & Development Tagged With: Massachusetts General Hospital

BTG’s Ekos device targets pulmonary embolism with drug, ultrasound wave combo therapy

March 13, 2017 By Sarah Faulkner

BTG's Ekos device targets pulmonary embolism with drug, ultrasound wave combo therapy

Each year, pulmonary embolisms kill more people in the U.S. than AIDs and breast cancer combined, according to BTG (LON:BTG). Venous clots in the legs or arm break off and travel through a patient’s circulatory system, eventually getting trapped in the lung and blocking the flow of blood. In some cases, this strains the heart’s ability to […]

Filed Under: Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Vascular Tagged With: BTG, Massachusetts General Hospital

Blood test could accurately diagnose heart disease

March 2, 2017 By Danielle Kirsh

A simple blood test could accurately diagnose heart disease in 2 hours, according to new data published by life science company Prevencio. Prevencio researchers and the Massachusetts General Hospital collaborated to develop a clinical and multi-protein blood test that could diagnose obstructions in coronary arteries, leading to the prevention of a heart attack. The blood test, known as […]

Filed Under: Cardiovascular Tagged With: coronary heart disease, Massachusetts General Hospital, medtech, Prevencio

Researchers’ bionic pancreas outperforms standard insulin pump therapy

December 21, 2016 By Sarah Faulkner

Researchers from Boston University have developed a bionic pancreas system that outperformed conventional insulin pump therapy for patients with type 1 diabetes, according to a trial conducted at Massachusetts General Hospital. The team’s work was published in The Lancet.  This device is the latest development in the race to make an entirely closed loop insulin pump system, […]

Filed Under: Clinical Trials, Diabetes, Drug-Device Combinations, Featured, Research & Development, Uncategorized Tagged With: Beta Bionics, Boston University, Massachusetts General Hospital, Medtronic

  • Page 1
  • Page 2
  • Go to Next Page »

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS